Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Reset all filters
01 5SANOFI AVENTIS US
02 3ACCORD HLTHCARE
03 2ACTAVIS
04 2ACTAVIS TOTOWA
05 2AM REGENT
06 2CHARTWELL MOLECULAR
07 2EUGIA PHARMA
08 2FRESENIUS KABI ONCOL
09 7FRESENIUS KABI USA
10 3GLAND
11 2GLAND PHARMA LTD
12 2HENGRUI PHARMA
13 2HETERO LABS LTD VI
14 2HOSPIRA INC
15 2HOSPIRA WORLDWIDE
16 2MEITHEAL
17 1MUSTAFA NEVSAT IIAC SANAYII A.S.
18 3MYLAN LABS LTD
19 2NORVIUM BIOSCIENCE
20 2NOVAST LABS
21 1PLIVA LACHEMA
22 5QILU PHARM HAINAN
23 6SANDOZ
24 5SUN PHARM
25 2TEVA PHARMS
Reset all filters
01 2INJECTABLE; INJECTION
02 67INJECTABLE;INTRAVENOUS
Reset all filters
01 32DISCN
02 35RX
03 2Blank
Reset all filters
01 5ELOXATIN
02 64OXALIPLATIN
01 60No
02 7Yes
03 2Blank
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : Yes
TE Code :
Brand Name : ELOXATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 2002-08-09
Application Number : 21492
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : Yes
TE Code :
Brand Name : ELOXATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 100MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 2002-08-09
Application Number : 21492
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : Yes
TE Code :
Brand Name : ELOXATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 50MG/10ML (5MG/ML)
Approval Date : 2005-01-31
Application Number : 21759
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : Yes
TE Code :
Brand Name : ELOXATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 100MG/20ML (5MG/ML)
Approval Date : 2005-01-31
Application Number : 21759
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : Yes
TE Code :
Brand Name : ELOXATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 200MG/40ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 2006-11-17
Application Number : 21759
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code :
Brand Name : OXALIPLATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 50MG/VIAL
Approval Date : 2012-08-08
Application Number : 78803
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : OXALIPLATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 100MG/VIAL
Approval Date : 2012-08-08
Application Number : 78803
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : OXALIPLATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 50MG/VIAL
Approval Date : 2009-08-07
Application Number : 78810
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code : AP
Brand Name : OXALIPLATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 50MG/10ML (5MG/ML)
Approval Date : 2009-08-07
Application Number : 22160
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP
RLD : Yes
TE Code : AP
Brand Name : OXALIPLATIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 100MG/20ML (5MG/ML)
Approval Date : 2009-08-07
Application Number : 22160
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AP